HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Yeon Cho Selected Research

kaempferol

12/2021Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells.
1/2018Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis.
9/2014Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells.
1/2013A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer.
5/2009A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Yeon Cho Research Topics

Disease

51Neoplasms (Cancer)
01/2022 - 06/2004
13Carcinogenesis
01/2022 - 06/2004
8Inflammation (Inflammations)
11/2021 - 05/2008
8Skin Neoplasms (Skin Cancer)
01/2020 - 08/2005
8Neoplastic Cell Transformation
10/2015 - 06/2004
7Colonic Neoplasms (Colon Cancer)
12/2021 - 07/2009
6Melanoma (Melanoma, Malignant)
01/2020 - 08/2005
5Lung Neoplasms (Lung Cancer)
01/2019 - 02/2014
3Gout
02/2021 - 06/2019
3Neoplasm Metastasis (Metastasis)
01/2021 - 06/2007
3Breast Neoplasms (Breast Cancer)
08/2019 - 02/2016
3Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 07/2009
2Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2021 - 01/2020
2Infections
11/2021 - 01/2021
2Mitochondrial Diseases (Mitochondrial Disease)
02/2021 - 01/2020
2Arthritis (Polyarthritis)
02/2021 - 01/2018
2Acne Vulgaris
09/2020 - 12/2018
2Rheumatoid Arthritis
09/2020 - 01/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 12/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2015 - 12/2010
2Basal Cell Carcinoma (Rodent Ulcer)
11/2015 - 01/2013
2Leukemia
11/2011 - 06/2007
1Poisoning
04/2022
1Body Weight (Weight, Body)
11/2021
1Obesity
11/2021
1Atopic Dermatitis (Atopic Eczema)
11/2021
1Dermatitis
11/2021
1Skin Diseases (Skin Disease)
11/2021
1Retinoblastoma (Glioblastoma, Retinal)
02/2021
1Disease Progression
01/2021
1Alcoholic Fatty Liver
04/2020

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2004
9Epidermal Growth Factor (EGF)IBA
02/2021 - 07/2005
9InflammasomesIBA
02/2021 - 12/2018
8AgarIBA
04/2019 - 03/2007
8Phosphotransferases (Kinase)IBA
01/2019 - 06/2004
6Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2021 - 07/2005
5kaempferolIBA
12/2021 - 05/2009
4Mitogen-Activated Protein KinasesIBA
01/2022 - 06/2006
4magnolinIBA
01/2019 - 02/2014
4Small Interfering RNA (siRNA)IBA
01/2017 - 06/2004
4CarcinogensIBA
11/2015 - 05/2008
3Uric Acid (Urate)IBA
02/2021 - 06/2019
3Pharmaceutical PreparationsIBA
01/2020 - 01/2013
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 11/2007
3AntioxidantsIBA
10/2018 - 09/2015
3Cyclin-Dependent Kinase Inhibitor p16IBA
04/2013 - 08/2005
3Histones (Histone)IBA
01/2011 - 07/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2020
2Pattern Recognition ReceptorsIBA
11/2021 - 01/2020
2celastrolIBA
11/2021 - 01/2019
2CytokinesIBA
11/2021 - 01/2019
2Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2021 - 12/2015
2Glutathione (Reduced Glutathione)IBA
01/2020 - 09/2015
2Adenosine Triphosphate (ATP)IBA
01/2020 - 01/2019
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
06/2019 - 03/2008
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2019 - 08/2005
2Pyrin Domain-Containing 3 Protein NLR FamilyIBA
01/2019 - 12/2018
2TOR Serine-Threonine KinasesIBA
01/2019 - 10/2015
2Biological ProductsIBA
11/2017 - 04/2010
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 09/2014
2Caspase 7IBA
11/2015 - 06/2012
2EnzymesIBA
09/2015 - 02/2015
2ErbB Receptors (EGF Receptor)IBA
12/2014 - 02/2009
2ResveratrolIBA
09/2014 - 12/2010
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2014 - 04/2010
2polypeptide 3 90kDa ribosomal protein S6 kinaseIBA
02/2014 - 01/2011
2eriodictyolIBA
01/2013 - 01/2011
2Protein Kinases (Protein Kinase)IBA
06/2012 - 06/2007
2Serine (L-Serine)FDA Link
06/2012 - 07/2005
2HydrolasesIBA
12/2010 - 07/2009
2Leukotriene A4IBA
12/2010 - 07/2009
2TeaIBA
03/2008 - 03/2006
1amatoxinIBA
04/2022
1Mitogen-Activated Protein Kinase 6IBA
01/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021
1Interleukin-4 (Interleukin 4)IBA
11/2021
1Thymic Stromal LymphopoietinIBA
11/2021
1Interleukin-5 (Interleukin 5)IBA
11/2021
1IFIH1 Interferon-Induced HelicaseIBA
11/2021
1Interleukin-13IBA
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2021
1AllergensIBA
11/2021
1CyclinsIBA
02/2021
1Cyclin EIBA
02/2021
1fargesinIBA
02/2021
1LignansIBA
02/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2021
1Cyclin-Dependent Kinase 2IBA
02/2021
1loganinIBA
02/2021
1Interleukin-18 (Interleukin 18)IBA
02/2021
1Phosphatidylcholines (Phosphatidylcholine)IBA
01/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
1Auranofin (Ridaura)FDA Link
09/2020
1GoldIBA
09/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2020
1Triglycerides (Triacylglycerol)IBA
04/2020

Therapy/Procedure

10Therapeutics
03/2020 - 07/2009
4Oral Administration
02/2021 - 11/2011
1Intraperitoneal Injections
04/2020